Magnesium and Cognition After Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBDH-Klinik Hessisch Oldendorf
About this trial
Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients.
Low serum-mg-concentrations are associated with cognitive impairments in ischemic stroke patients one month after stroke onset. It is not clear, if cognitive impairments after stroke is caused by the mg-deficiency or by the stroke itself. Until now, no studies investigating the relationship between mg-concentration, stroke severity and cognition during treatment course are available. Thus, this study aimed to investigate the relationship between mg-concentration and cognition of stroke patients.
Eligibility criteria
Qualifiers
ischemic/hemmorhagic stroke
written consent form
Disqualifiers
pre-existing dementia or cognitive impairment before stroke onset
pre-existing mental disorder (depression) or present/prior long-term treatment (> 6 months) with psychotropic drugs
pre-existing malign tumor disease
participation in another clinical trial within the past 30 days
Trial design
Treatments tested in this trial
- Kölner Neuropsychologische Screening für Schlaganfall-Patienten
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov